XODUS MEDICAL v. Mullen: Surgical Pad Patent Case Ends in Dismissal
What would you like to do next?
Choose your path based on your current needs:
📋 Case Summary
| Case Name | XODUS MEDICAL, Inc. v. Mark Mullen |
| Case Number | 7:21-cv-00727 |
| Court | U.S. District Court for South Carolina |
| Duration | Mar 2021 – Jan 2026 4 years 10 months |
| Outcome | Dismissed Without Prejudice |
| Patents at Issue | |
| Accused Products | SurgyPad |
Case Overview
After nearly five years of litigation spanning 1,770 days, XODUS MEDICAL, Inc. v. Mark Mullen concluded not with a courtroom verdict but with a stipulated dismissal without prejudice — a resolution that raises as many strategic questions as it answers. Filed on March 12, 2021, in the U.S. District Court for South Carolina under Case No. 7:21-cv-00727, the case centered on three U.S. patents covering surgical positioning and patient protection technology, with XODUS MEDICAL alleging infringement tied to its proprietary **SurgyPad** product line.
For patent attorneys tracking medical device IP litigation, IP professionals monitoring surgical equipment patent trends, and R&D teams assessing freedom-to-operate risk in the operating room technology space, this case offers a textbook example of how prolonged district-court proceedings can culminate in a negotiated exit — and what that outcome signals about litigation leverage, portfolio strength, and commercial risk calculus in the medical device sector.
The Parties
⚖️ Plaintiff
A medical device company focused on surgical patient safety products, including warming and positioning solutions used in operating room environments. Holds a notable patent portfolio directed at surgical pad technology.
🛡️ Defendant
Named as an individual defendant in this infringement action. The specific commercial or inventive role attributed to Mullen in relation to the accused products was not publicly elaborated.
Patents at Issue
This case involved three U.S. patents covering surgical positioning and patient protection technology. Together, these patents represent a coordinated IP portfolio protecting overlapping aspects of surgical pad design and functionality — a common multi-patent assertion strategy intended to maximize claim coverage and litigation leverage.
- • US 8,511,314 B2 — Surgical pad technology
- • US 8,464,720 B1 — Patient protection apparatus claims
- • US 9,161,876 B2 — Surgical positioning and safety pad technology
Designing a similar medical device product?
Check if your surgical pad design might infringe these or related patents before launch.
The Verdict & Legal Analysis
Outcome
The case was resolved by stipulated dismissal without prejudice pursuant to Federal Rule of Civil Procedure 41(a)(1)(A)(ii). Per the parties’ stipulation, each side agreed to bear its own attorneys’ fees and costs. No damages award, injunctive relief, or consent judgment was entered.
Key Legal Issues
The case was brought as a straightforward patent infringement action. Because the matter resolved by mutual stipulation rather than judicial ruling, no formal claim construction order, invalidity finding, or infringement determination was issued by the court. As a result, the three patents-in-suit — US8511314B2, US8464720B1, and US9161876B2 — emerge from this litigation with their validity formally unchallenged by any court ruling.
The absence of a damages figure or injunctive outcome is consistent with a privately negotiated resolution, whether that took the form of a licensing agreement, a covenant not to sue, a design-around arrangement, or a purely commercial settlement whose terms were not made part of the public record.
Freedom to Operate (FTO) Analysis
This case highlights critical IP risks in medical device design, especially surgical pads. Choose your next step:
📋 Understand This Case’s Impact
Learn about the specific risks and implications from this litigation.
- View all related patents in this medical device technology space
- See which companies are most active in surgical pad patents
- Understand claim construction patterns
🔍 Check My Product’s Risk
Run a comprehensive FTO analysis for your own technology or product.
- Input your product description or technical features
- AI identifies potentially blocking patents
- Get actionable risk assessment report
High Risk Area
Surgical pads with specific positioning features
3 Patents at Issue
In surgical pad technology
Design-Around Options
Available for many aspects of design
✅ Key Takeaways
Multi-patent assertion from related application families (US13/773290, US13/737552, US13/957778) strengthens infringement claims and complicates invalidity defenses.
Search related case law →A Rule 41(a)(1)(A)(ii) without-prejudice dismissal preserves enforcement rights — distinguish from with-prejudice outcomes when advising clients on settlement structures.
Explore precedents →No claim construction issued — the three XODUS MEDICAL patents carry forward without adverse judicial interpretation, preserving portfolio value.
Analyze claim scope →Surgical pad and OR safety product development requires proactive FTO analysis against active portfolios like those involving US8511314B2, US8464720B1, and US9161876B2.
Start FTO analysis for my product →Individual inventors and small companies commercializing products in patented spaces face significant litigation exposure without early IP clearance.
Assess my IP risk →Frequently Asked Questions
Three U.S. patents: US8,511,314 B2, US8,464,720 B1, and US9,161,876 B2 — all directed at surgical pad and patient protection technology.
The parties stipulated to dismissal under FRCP 41(a)(1)(A)(ii), with each bearing its own costs. No public explanation was provided, consistent with a privately negotiated resolution.
It reinforces the viability of multi-patent enforcement strategies in OR safety technology and signals that without-prejudice resolutions remain a preferred exit mechanism in medical device IP disputes.
Ready to Strengthen Your Patent Strategy?
Join 18,000+ IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyse competitive landscapes with AI-powered precision.
PatSnap IP Intelligence Team
Patent Research & Competitive Intelligence · PatSnap
This analysis was produced by the PatSnap IP Intelligence Team — a group of patent analysts, IP strategists, and data scientists who work daily with PatSnap’s global patent database of over 2 billion structured data points across patents, litigation records, scientific literature, and regulatory filings.
The team specialises in tracking landmark litigation outcomes, translating complex court rulings into actionable IP strategy, and identifying the competitive intelligence implications for R&D and legal teams. All case analysis is grounded in primary sources: official court records, USPTO filings, and Federal Circuit opinions.
References
- U.S. District Court for the District of South Carolina — Case 7:21-cv-00727
- U.S. Patent and Trademark Office — Patent Resources
- PACER – Public Access to Court Electronic Records (Case No. 7:21-cv-00727, D.S.C.)
- Cornell Legal Information Institute — Federal Rule of Civil Procedure 41
- PatSnap — IP Intelligence Solutions for Law Firms
This article is for informational purposes only and does not constitute legal advice. All case information is drawn from publicly available court records. For platform capabilities, visit PatSnap.
📑 Table of Contents
🚀 PatSnap Eureka IP Tools
🔍Novelty Search
Find prior art instantly
Patent Drafting
AI-assisted claim writing
FTO Analysis
Assess infringement risk
Concerned About Your Medical Device Product?
Don’t wait for litigation. Check your product’s freedom to operate now with AI-powered analysis for surgical equipment.
Run FTO for My Product